Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

Abstract Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer. This statement is based on a phase III multicenter, randomized clinical trial that lacks a descri...

Full description

Bibliographic Details
Main Authors: Juan José Segura-Sampedro, Rafael Morales-Soriano, Álvaro Arjona-Sánchez, Pedro Cascales-Campos
Format: Article
Language:English
Published: BMC 2020-05-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-020-01853-4

Similar Items